GRM1 and melanoma: Similar to the primary tumor data described above, results showed significantly reduced melanoma in the lymph nodes of Grm1/SELENOK–/– mice compared to Grm1/SELENOK+/– and Grm1/SELENOK+/+ mice, which were similar to each other.